Session 6, Alliance Case study

<p>Cardiovascular Health (A)</p> Signup and view all the answers

<p>$1,400 (C)</p> Signup and view all the answers

<p>46,000 (D)</p> Signup and view all the answers

<p>Aspirin (B)</p> Signup and view all the answers

<p>1876 (B)</p> Signup and view all the answers

<p>To enhance Lilly's partnership capabilities and manage alliances. (C)</p> Signup and view all the answers

<p>Nelson Sims (A)</p> Signup and view all the answers

<p>A road map to streamline and simplify alliance management. (C)</p> Signup and view all the answers

<p>Research Acquisitions group (B)</p> Signup and view all the answers

<p>Accenture (C)</p> Signup and view all the answers

<p>18 months (A)</p> Signup and view all the answers

<p>Negotiations and due diligence. (D)</p> Signup and view all the answers

<p>Development of a structured process for managing alliances. (C)</p> Signup and view all the answers

<p>Cancer diagnostic technologies (D)</p> Signup and view all the answers

<p>$100 million (D)</p> Signup and view all the answers

<p>Alliance manager (B)</p> Signup and view all the answers

<p>Research alliance (B)</p> Signup and view all the answers

<p>Establishing governance committees (D)</p> Signup and view all the answers

<p>Gene transcription technology (C)</p> Signup and view all the answers

<p>1992 (A)</p> Signup and view all the answers

<p>$75 million (A)</p> Signup and view all the answers

<p>Equipping teams with intercultural skills for global collaborations. (A)</p> Signup and view all the answers

<p>Sankyo and Boehringer Ingelheim. (C)</p> Signup and view all the answers

<p>Opportunities for enhanced offshoring of research services. (C)</p> Signup and view all the answers

<p>Avoiding overlap and duplication with OAM processes. (B)</p> Signup and view all the answers

<ol start="30"> <li>(A)</li> </ol> Signup and view all the answers

<p>Intercultural communication skills. (D)</p> Signup and view all the answers

<p>To enhance offshoring capabilities for pre-clinical trials. (B)</p> Signup and view all the answers

<p>Increased number of local partnerships in foreign markets. (D)</p> Signup and view all the answers

<p>Aventis (D)</p> Signup and view all the answers

<p>Pharmacia (C)</p> Signup and view all the answers

<p>Zenecca (A)</p> Signup and view all the answers

<p>2000 (C)</p> Signup and view all the answers

<p>Wellcome (D)</p> Signup and view all the answers

<p>Lipitor (A)</p> Signup and view all the answers

<p>Abbott (C)</p> Signup and view all the answers

<p>Plavix (B)</p> Signup and view all the answers

<p>Takeda (A)</p> Signup and view all the answers

<p>$5.203 billion (A)</p> Signup and view all the answers

<p>It occurred in 1995. (D)</p> Signup and view all the answers

<p>Johnson &amp; Johnson (B)</p> Signup and view all the answers

<p>Zocor (D)</p> Signup and view all the answers

<p>Seretide/Advair (B)</p> Signup and view all the answers

<p>To ascertain the safety of the drug in healthy volunteers (B)</p> Signup and view all the answers

<p>Phase II (A)</p> Signup and view all the answers

<p>They assess the drug's safety and efficacy in a larger population (C), They are the final stage of testing before a NDA is filed (D)</p> Signup and view all the answers

<p>$30 million to $100 million (D)</p> Signup and view all the answers

<p>85 percent or more (C)</p> Signup and view all the answers

The process of testing a new drug to see if it is safe and effective in humans.

The stage of drug development where the drug is tested on a large group of people to confirm its effectiveness and monitor for side effects.

The type of alliance where two companies combine their brands to market a single product.

The type of alliance where two companies market the same product in different geographic areas, each under their own brand.

A partnership between two or more companies to achieve a common goal, such as developing, manufacturing, or marketing a product.

The process of developing a new drug, from initial research to clinical trials and final approval.

The process of translating research findings into a marketable product, involving various steps like manufacturing and packaging.

The process of promoting and selling a product to consumers, often involving partnerships and collaborations.

Lilly's dedicated unit for managing partnerships, established in 1999. It was designed to streamline the alliance management process and improve Lilly's partnering capabilities.

A structured process developed by Lilly to guide and standardize the management of partnerships or alliances. It focuses on a clear roadmap, making partnering more efficient and effective.

Identifying and evaluating potential partners or opportunities for collaboration. It involves understanding their strengths, capabilities, and potential fit with Lilly's goals.

Conducting thorough due diligence on potential partners, reviewing their financial health, technology, and alignment with Lilly's goals. This involves negotiations and finalizing partnership agreements.

This group focuses on ensuring the smooth operation and success of the partnership. It involves monitoring progress, managing challenges, and ensuring the partnership delivers intended outcomes.

Experts from Accenture, known for their work with tech companies, were brought in to review and enhance Lilly's partnership processes.

A firm used to conduct an independent assessment of Lilly's existing partnership practices and identify areas for improvement.

Nelson Sims, with his extensive experience at Lilly, led the development of OAM and LAMP. He was instrumental in shaping Lilly's approach towards partnerships.

A type of business partnership where companies collaborate on research and development, sharing resources and expertise to develop new products or technologies.

A company focused on developing and commercializing diagnostic technologies for cancer.

A technology used to modify or alter the genetic makeup of organisms, providing a powerful tool for developing new drugs and treatments.

An individual responsible for managing and coordinating activities within a business partnership. This can include tasks like setting up governance committees, managing communication, and ensuring alignment of goals.

A meeting or group of people responsible for overseeing and guiding the activities of a partnership, providing direction and ensuring the strategic alignment of the collaboration.

A payment made to a partner in a business alliance to compensate them for their contributions and milestones achieved, providing financial incentive and motivating progress.

The process of building relationships and trust among team members from different companies involved in a partnership, enabling effective collaboration and communication.

A senior scientist from Lilly who played a significant role in managing the research partnership with Alpha, focusing on overseeing and guiding the research activities.

The process of extending alliances to new locations (geographically) and incorporating different operational functions within the value chain.

A partnership between two or more companies to achieve a common goal, such as developing, manufacturing, or marketing a product.

A strategic approach used by companies to manage the relationships with external partners for activities like research, manufacturing, and marketing.

Companies specializing in conducting clinical trials, often outsourcing research services to countries like India and China.

The process of transferring some business activities to a third-party supplier, often in another country, to reduce costs or leverage specialized skills.

The function responsible for managing relationships with suppliers, negotiating prices, and ensuring quality standards.

Tools and processes used to manage supplier relationships, including tracking performance and negotiating contracts.

The practice of combining different skills and resources from various locations across the globe, especially for international alliances.

Phase III clinical trials expand the study to a larger group of patients (2000-3000) across multiple centers, confirming the drug's effectiveness and monitoring side effects in a more representative population. This stage often involves significant costs and is crucial for drug approval.

A document submitted to the FDA (or comparable regulatory agencies in other countries) after a successful Phase III clinical trial, requesting approval to market a new drug.

The process of evaluating a drug's safety and effectiveness through a series of stages involving human testing. It involves closely monitoring participants, collecting data, and reviewing results.

Hoechst and Rhone merged in 1999 to create Aventis, a major pharmaceutical company.

Hoffman-LaRoche simplified its name to simply Roche, a well-known pharmaceutical corporation.

ICI, a company in the pharmaceutical industry, spun off its pharmaceutical division as Zenecca in 1993.

Zenecca, a pharmaceutical company spun off from ICI, merged with Astra to form AstraZeneca.

Knoll, a pharmaceutical company, was acquired by Abbott in 2001.

Marion Laboratories was acquired by Dow Chemical Company in 1989, and later merged with Bristol-Myers Squibb.

Merrell Dow, a pharmaceutical company, was acquired by Hoechst in 1995, and later became part of the Aventis merger.

Pharmacia, a major pharmaceutical company, was acquired by Pfizer in 2002.

R.P. Scherer, Rorer, and Roussel all merged with Aventis, creating a massive pharmaceutical force.

Sterling Drug merged with Eastman Kodak and moved out of the pharmaceutical sector.

Upjohn, a pharmaceutical company, merged with Pharmacia in 1995, and later became part of Pfizer through Pharmacia's acquisition.

Warner-Lambert, a large pharmaceutical company, was acquired by Pfizer in 2000.

Wellcome, a pharmaceutical company, merged with Glaxo in 2000, eventually forming the giant GlaxoSmithKline (GSK).

These mergers and acquisitions shaped the pharmaceutical industry, resulting in companies like Pfizer, GlaxoSmithKline, and Sanofi-Aventis becoming global giants.

The pharmaceutical industry has seen numerous mergers and acquisitions throughout its history, leading to consolidation and change in the landscape of companies.